As more clinically relevant findings, it was recently reported that transcripts encoding PTPRZ were highly expressed in individual cells by single-cell RNA sequencing of primary human glioblastomas, and analyses of intratumoral heterogeneity annotated PTPRZ as the major positive regulator of cancer stemness in vivo (ref. 14). This evidence concerns the gene PTPRZ1 and glioblastoma.